Viewing StudyNCT02245022


Ignite Creation Date: 2025-12-18 @ 9:58 AM
Ignite Modification Date: 2025-12-18 @ 9:58 AM
Study NCT ID: NCT02245022
Status: None
Last Update Posted: 2025-09-04 00:00:00
First Post: 2014-09-12 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Pharmacokinetics of Dolutegravir in Pregnant HIV Mothers and Their Neonates: A Pilot Study
Sponsor: None
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-03-14
Start Date Type: ACTUAL
Primary Completion Date: 2018-12-06
Primary Completion Date Type: ACTUAL
Completion Date: 2018-12-06
Completion Date Type: ACTUAL
First Submit Date: 2014-09-12 00:00:00
First Submit QC Date: None
Study First Post Date: 2014-09-19
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2022-12-13 00:00:00
Results First Submit QC Date: None
Results First Post Date: 2025-09-04
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-09-01 00:00:00
Last Update Post Date: 2025-09-04 00:00:00
Last Update Post Date Type: ESTIMATED